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The severity of muscle ischemia during
intermittent claudication
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Maureen S. Thorniley, DPhil,b and Charles N. McCollum, FRCS, MD,a Manchester, United Kingdom
Purpose: The degree of ischemia during intermittent claudication is difficult to quantify. We evaluated calf muscle
ischemia during exercise in patients with claudication with near infrared spectroscopy.
Methods: A Critikon Cerebral Redox Model 2001 (Johnson & Johnson Medical, Newport, Gwent, United Kingdom) was
used to measure calf muscle deoxygenated hemoglobin (HHb), oxygenated hemoglobin (O2Hb), and total hemoglobin
levels and oxygenation index (HbD; HbD  O2Hb HHb) in 16 patients with claudication and in 14 control subjects
before, during, and after walking on a treadmill for 1 minute (submaximal exercise). These measures were repeated after
a second maximal exercise in patients with claudication and after 7 minutes walking in control subjects. Near-infrared
spectroscopy readings during maximal exercise were then compared with a model of total ischemia induced with
tourniquet in 16 young control subjects.
Results: Total hemoglobin level changed little during exercise in both patients with claudication and control subjects.
HHb levels rose, and O2Hb level and HbD falls were more pronounced in patients with claudication than in control
subjects after submaximal and maximal exercise. During maximal exercise, HbD fell markedly by a median (interquartile
range) of 210.5 mol/cm (108.2 to 337.0 mol/cm) in patients with claudication compared with 66.0 mol/cm (44.0
to 101.0 mol/cm) in elderly control subjects and 41.0 mol/cm (36.0 to 65.0 mol/cm) in young control subjects
(P < .001). This fall also was greater than the HbD fall induced with tourniquet ischemia at 90.8 mol/cm (57.6 to
126.2 mol/cm; P  .006).
Conclusion: Hemoglobin desaturation in exercising calf muscle is profound in patients with claudication, considerably
greater even than that induced with three minutes of tourniquet occlusion. Further studies are necessary to investigate the
relationship between the inflammatory response and near-infrared spectroscopy during exercise in patients with
claudication. (J Vasc Surg 2002;36:89-93.)
Intermittent claudication is a cramp-like pain in the leg
muscles induced with exercise and is the most frequent
chronic symptom of atherosclerosis, which affects more
than 5% of men more than 50 years of age.1 Most patients
undergo conservative management and rarely need vascular
surgery.2 Few have progression to limb-threatening is-
chemia, but mortality rates from myocardial infarction and
stroke are high, with 30% to 40% dying within 5 years of
diagnosis.3-6 Claudication appears to be associated with
subsequent cardiovascular events, such as myocardial in-
farction and stroke.7
That repetitive low-grade ischemia reperfusion of leg
muscles on walking leads to leukocyte and platelet activa-
tion and an inflammatory cascade involving free radicals,
arachidonic acid metabolites, cytokines, adhesion mole-
cules, and endothelial damage is known.8-10 Although the
mortality rate in patients with claudication is clearly related
to the high prevalence of cardiac and cerebrovascular dis-
ease, the inflammatory response generated by exercise has
been suggested to contribute to the poor prognosis.
The degree of ischemia induced with claudication is
difficult to quantify. Nuclear magnetic resonance spectros-
copy, which measures high energy metabolites in muscle,
and near-infrared spectroscopy (NIRS), a noninvasive tech-
nique measuring tissue oxygenation and perfusion, have
been proposed to assess metabolic changes as the result of
intermittent claudication and to monitor the effect of med-
ical therapy.11-17 We used NIRS to investigate the severity
of calf muscle ischemia induced with exercise in patients
with claudication. We hypothesized that exercise would
induce profound hemoglobin desaturation in the calf mus-
cle of patients with claudication compared with exercise
and short duration of ischemia in healthy individuals.
METHODS
Subjects. After ethical approval and informed consent,
16 patients with claudication were recruited. All had a
typical clinical history of calf claudication, with cramp-like
pain occurring after walking a fixed distance and resolving
with rest. They were included in the study if the resting
ankle brachial pressure index (ABPI) was less than 0.8.
Patients with claudication were excluded for evidence of
critical limb ischemia (rest pain, ulcer, or gangrene), cardiac
failure, or impaired mobility from any cause. Patients with
claudication and diabetes also were excluded because their
ABPIs could not be measured reliably.
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Patients with claudication were compared with 14
healthy control subjects who comprised seven matched for
gender and age (elderly control subjects) and seven aged
between 20 and 30 years (young control subjects). All were
required to have an ABPI of more than 1 with no fall on
exercise. Sixteen young adults also were recruited to mea-
sure the severity of hypoxia and oxygen extraction during
complete calf muscle ischemia.
Near-infrared spectroscopy. Reflectance NIRS is
based on the Beer-Lambert law,18 the relative transparency
of biologic tissues to near infrared light and the character-
istic absorption in the near infrared spectrum of hemoglo-
bin, myoglobin, and cytochrome oxidase. Because the
light-absorbing properties of these molecules vary with
oxygenation, changes in their concentration can be mea-
sured. Myoglobin and cytochrome oxidase, however, are
robust to large changes in oxygen supply. Hence, the
variation in absorption detected with NIRS is, in most
circumstances, the result of changes in hemoglobin oxida-
tion and concentration. Changes in hemoglobin concen-
tration (tHb) reflect variations in regional blood volume,19
and changes in hemoglobin oxidation reflect the balance
between oxygen supply and consumption.20,21
In vivo, near infrared light is scattered by the difference
in refraction between tissue constituents, leading to an
elongation of the path of the light beam. To measure
absolute hemoglobin concentrations with NIRS, knowl-
edge of the length of this path is necessary, with addition of
a “pathlength factor” (specific to patient and tissues) to the
Beer-Lambert law. Because pathlength is difficult to mea-
sure in vivo, only changes from an arbitrary baseline are
usually measured, with NIRS as a trend monitor.
We used a Critikon Cerebral Redox Research Model
2001 (Johnson & Johnson Medical, Newport, Gwent,
United Kingdom), a four wavelength spectroscope emit-
ting light at 776, 819, 871, and 909 nm. This instrument
was used with a sensor with a 3.5-cm distance between light
source and detector. The Cerebral Redox Model provides a
continuous output for changes in concentration of total
(tHb), oxygenated (O2Hb), and deoxygenated hemoglo-
bin (HHb). The oxygenation index (HbD; HbD 
O2HbHHb), a previously validated parameter reflecting
tissue oxygen use,22 was calculated. HbD gives an indica-
tion of the net hemoglobin oxygenation status irrespective
of blood volume changes and reflects the balance between
oxygen supply and consumption and is affected by changes
in perfusion pressure. Hemoglobin concentration changes
were expressed as mol/cm because tissue changes in
absorption are related to the distance travelled by the light
beam through the tissues.
Study plan. Patients with claudication and control
subjects fasted for 8 hours and were asked to refrain from
any physical activity on the morning of the study. On arrival
to our unit, they were rested for 1 hour on a couch. The
NIRS probe then was secured to the calf muscle with a
self-adhesive bandage. In patients with claudication, the
symptomatic leg was studied; if claudication was bilateral,
the leg with most severe symptoms was chosen. The right
leg was studied in control subjects. A general physical
examination then was carried out and included measure-
ment of systolic and diastolic brachial pressure in the right
arm and ankle arterial pressures with a hand-held Doppler
scan (Huntleigh Diagnostics, Cardiff, South Glamorgan,
United Kingdom). The ABPI was calculated as the ratio
between the highest pressure measured at the ankle (dor-
salis pedis, posterior tibial, or peroneal artery) and the
systolic brachial pressure.
Baseline NIRS recordings were taken during a 10
minute period. To evaluate the response of each group to
submaximal exercise, a 1-minute walk on a treadmill then
was performed at a speed of 3.2 kph and a gradient of 10
degrees. After a further 20-minute rest period on a couch,
all subjects were asked to walk again at the same speed and
inclination for 7 minutes or, for patients with claudication,
until stopped with pain. This second test was to evaluate the
response of patients with claudication to maximal exercise.
NIRS measurements were taken every second during exer-
cise and continued until values returned to their original
resting levels (recovery period) with subjects lying on a
couch.
In the model of complete ischemia, a tourniquet was
inflated to twice the systolic blood pressure for 3 minutes
around mid-thigh in 16 young healthy control subjects. A
hand-held Doppler scan was used to confirm total cessation
of blood flow in the superficial femoral artery. An ischemic
time of 3 minutes was chosen to equate the median maxi-
mum walking time for patients with claudication during
maximal exercise.
Data analysis. All results were entered on a purpose-
designed database for further analysis. Data were analyzed
with Excel 5.0 (Microsoft, Reno, Nev) and SPSS 9.0 (SPSS
Inc, Chicago, Ill). Comparisons were made between pa-
tients with claudication and control subjects with changes
in NIRS readings on exercise. Because NIRS data were
skewed, a log transformation was attempted but did not
produce a satisfactory fit to the normal distribution for all
variables. The Kruskal-Wallis and Mann-Whitney U tests
therefore were used to compare the groups, with the Spear-
man correlation test to explore associations between vari-
ables. Statistical significance was set at the standard .05 level.
RESULTS
Demographics, smoking habits, walking times, and
ABPIs of the subjects studied are summarized in Table I.
Submaximal exercise (Table II). During the first
exercise, a rise in HHb in all subjects was seen. This was
more pronounced in patients with claudication, at a median
(interquartile range) of 81 mol/cm (21.9 to 180.5
mol/cm), compared with elderly control subjects, at 25.1
mol/cm (15.8 to 37.9 mol/cm), and young control
subjects, at 11.7 mol/cm (3.8 to 46.8 mol/cm; P 
.038). A fall in O2Hb in all subjects also was seen, especially
in patients with claudication, but the difference was not
statistically significant (P .11), although tHb rose slightly
in all subjects. The fall in HbD was much greater in patients
with claudication, at 168.7 mol/cm (46.7 to 297.3
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mol/cm), compared with elderly control subjects, at 40.5
mol/cm (24.8 to 74.8 mol/cm), and young control
subjects, at 38.4 mol/cm (18 to 45.6 mol/cm; P 
.007). In the recovery period, patients with claudication
showed a rise in O2Hb, tHb, and HbD not seen in control
subjects.
Maximal exercise (Table III). The median (range)
time walked on the treadmill by patients with claudication
was 3 minutes (1 to 5 minutes). All control subjects were
able to walk for 7 minutes without pain. Similar qualitative
changes in tissue oxygenation were found during maximal
walking in patients with claudication and during 7 minutes
of walking in control subjects. However, the rise in HHb
(P .003) and the falls in O2Hb (P .001) and HbD (P
.001) were significantly more pronounced in patients with
claudication. During the recovery period, the rise in O2Hb
and HbD seen in patients with claudication was greater
than those seen in control subjects. A significant correlation
was found between resting ABPI and HHb rise in exercis-
ing patients with claudication (r.45; P .05), but the
correlation between resting ABPI and the fall in O2Hb (r
.10; P .07) and HbD (r .37; P .15) on exercise were
poor. Also, no correlation was found between NIRS mea-
surements and ABPI falls during exercise.
Tourniquet ischemia. Complete tourniquet-induced
ischemia over 3 minutes in healthy control subjects resulted
Table I. Subjects
Claudication
(n  16)
Matched controls
(n  7)
Young controls
(n  7)
Tourniquet
ischemia
(n  16)
Mean age (range) (y) 63 (53-79) 62 (52-78) 24 (20-30) 29 (23-38)
Men/women 8/8 4/3 3/4 9/7
Smokers 3 1 2 3
Median MWT (range) (min) 3 (1-5) Unlimited Unlimited Unlimited
Mean resting ABPI (range) 0.68 (0.44-0.8) 1 1 1
Mean post-exercise ABPI (range) 0.52 (0.3-0.71) 1 1 1
MWT, Maximum walking time on treadmill.
Table II. Changes in NIRS parameters (mol/cm) in patients with claudication and in control subjects during and
after submaximal exercise
Patients with claudication Elderly controls Young controls
During exercise
HHb 81.0 (21.9, 180.5) 25.1 (15.8, 37.9) 11.7 (3.8, 46.8)
O2Hb –64.8 (–162.3, –17.3) –24.4 (–11.0, –30.6) –23.3 (–21.9, –32.5)
tHb 19.3 (–47.2, 64.5) 9.5 (–20.1, 17.2) 18.0 (–25.4, 26.0)
HbD –168.7 (–46.7, –297.3) –40.5 (–24.8, –74.8) –38.4 (–18.0, –45.6)
After exercise
HHb –0.8 (–23.5, 5.2) –0.20 (–6.0, 8.8) 3.8 (–4.2, 8.3)
O2Hb 20.8 (3.4, 59.2) 2.6 (–3.6, 17.9) 3.7 (–5.8, 18.9)
THb 38.0 (5.9, 56.1) 0.9 (–1.8, 26.6) 8.1 (2.4, 28.6)
HbD 21.4 (0.7, 79.1) 7.7 (–6.6, 12.5) 3.4 (–0.9, 20.6)
Values are median (interquartile range).
Table III. Changes in NIRS parameters (mol/cm) in patients with claudication and in control subjects during and
after maximal exercise
Patients with claudication Elderly controls Young controls
During exercise
HHb 86.5 (41.7, 193.0) 32.0 (11.0, 60.0) 21.0 (5.0, 45.0)
O2Hb –107.5 (–48.7, –178.7) –41.0 (–69.0, 14.0) –18.0 (–41.0, 16.0)
tHb –12.5 (–55.7, 47.5) –27.0 (–49.0, 21.0) 7.0 (–23.0, 20.0)
HbD –210.5 (–108.2, –337.0) –66.0 (–44.0, –101.0) –41.0 (–36.0, –65.0)
After exercise
HHb –6.9 (–1.1, –22.2) –2.7 (–5.8, 0.7) –8.2 (–3.8, –17.4)
O2Hb 24.2 (1.4, 47.7) 10.0 (2.6, 18.0) 9.2 (6.9, 28.3)
tHb 5.0 (–2.3, 40.1) 0.6 (–22.5, 15.5) 3.2 (–6.5, 18.2)
HbD 47.3 (–0.12, 76.0) 17.0 (10.0, 25.6) 26.5 (11.5, 38.8)
Values are median (interquartile range).
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in a median (interquartile range) HHb rise of 35.0
mol/cm (20.3 to 79.2 mol/cm), and O2Hb and HbD
fell by 59.4 mol/cm (28.0 to 73.8 mol/cm) and 90.8
mol/cm (57.6 to 126.2mol/cm), respectively, but tHb
did not change. The fall in HbD during maximal walking in
patients with claudication was 210.5 mol/cm (108.2 to
337.0 mol/cm), significantly greater than during tourni-
quet ischemia (P  .006; Fig).
DISCUSSION
According to our hypothesis, we showed profound
hemoglobin desaturation in the calf muscles of patients
with claudication during exercise. This desaturation was
more marked than in elderly or young control subjects and,
in accordance with previous reports,23 was not accompa-
nied by large changes in regional blood volume, measured
with tHb. NIRS changes in patients with claudication
during maximal exercise were similar but more pronounced
than those seen during complete interruption of blood flow
in healthy individuals, suggesting that walking induces
severe ischemia in patients with peripheral vascular disease.
In contrast with previous studies,17,23 we did not find a
strong correlation between NIRS and ABPIs. Our findings
are consistent with the pathogenesis of claudication pain,
because of the circulation failing to meet increased oxygen
requirements during exercise. The rise in HHb and the falls
in O2Hb and HbD show increased oxygen extraction with
muscles during walking compensating for insufficient oxy-
gen delivery.
NIRS has been used previously to investigate tissue
oxygenation in peripheral vascular disease16 and grade the
severity of intermittent claudication.17,24-25 Recently,
Komiyama et al,26 evaluating NIRS in patients with claudi-
cation with diabetes, concluded that NIRS measured the
hemodynamic severity of peripheral vascular disease more
accurately than resting ABPI. NIRS has also been used to
diagnose peripheral vascular disease in the elderly, for peri-
operative monitoring of vascular patients, and to assess the
effect of hemodialysis in patients with peripheral vascular
disease.25-27 Although nuclear magnetic resonance spec-
troscopy also has been used to evaluate ischemia in patients
with claudication, NIRS has significant advantages because
it is cheaper, widely available, and easy to use. It is, how-
ever, reassuring that changes in saturation measured with
NIRS and metabolic alterations measured with nuclear
magnetic resonance spectroscopy show similar trends dur-
ing muscular contraction.28,29
Although our data do not directly support an ischemia
reperfusion injury, we confirmed that ischemia in the calf
muscles of patients with claudication is severe. Future stud-
ies may investigate a potential correlation between the
magnitude of the inflammatory response to exercise and
NIRS changes in patients with claudication. If the degree of
desaturation measured with NIRS could predict this re-
sponse and if remote organ damage was shown to occur in
response to inflammation, NIRS may become a useful tool
not only to assess the severity of ischemia but also to
identify patients with claudication with poor prognosis.
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